Skip to main content
Livermore
Livermore
ZHEN

Replimune Group, Inc.

REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001737953

In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Replimune Group, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of REPL: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1502149+1
Shares67.0M38.6K70.9M+3.90M (+5.8%)
Value$547.8M$314.3K$638.1M+$90.7M (+16.6%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Replimune Group, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to REPL in Q2 2024
InstitutionSharesValue% of portfolio
Boxer Capital, LLC1,536,341$13.8M0.73%
RTW Investments, LP1,133,787$10.2M0.16%
Braidwell LP1,013,377$9.12M0.29%
EcoR1 Capital, LLC850,341$7.65M0.23%
Tang Capital Management LLC805,440$7.25M0.74%
Parkman Healthcare Partners LLC525,000$4.72M0.64%
HRT Financial LP184,761$1.66M0.01%
PDT Partners, LLC158,770$1.43M0.14%
Cantor Fitzgerald, L. P.145,919$1.31M0.26%
J. Goldman & Co LP136,050$1.22M0.05%
Campbell & CO Investment Adviser LLC70,113$631.0K0.05%
Atom Investors LP66,071$594.6K0.06%
Y-Intercept (Hong Kong) Ltd52,112$469.0K0.03%
Point72 Asia (Singapore) Pte. Ltd.49,261$443.4K0.09%
LMR Partners LLP33,559$302.0K0.01%
Alyeska Investment Group, L.P.29,460$265.1K0.00%
Corebridge Financial, Inc.27,061$243.5K0.00%
Mirae Asset Global ETFs Holdings Ltd.24,405$219.6K0.00%
Engineers Gate Manager LP22,680$204.1K0.00%
Laurion Capital Management LP19,707$177.4K0.01%
Ameriprise Financial Inc18,555$167.0K0.00%
Arizona State Retirement System12,029$108.3K0.00%
Centiva Capital, LP11,134$100.2K0.00%
Point72 (DIFC) Ltd6,325$56.9K0.01%
Smartleaf Asset Management LLC367$3.13K0.00%
Parallel Advisors, LLC344$3.10K0.00%
EverSource Wealth Advisors, LLC157$1.57K0.00%
Rothschild Investment LLC15$1350.00%

Sold out (27)

Institutions that held Replimune Group, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of REPL in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Rafferty Asset Management, LLC642,078$5.25M
Emerald Advisers, LLC492,219$4.02M
Clearbridge Investments, LLC277,969$2.27M
Qube Research & Technologies Ltd221,222$1.81M
ExodusPoint Capital Management, LP171,015$1.40M
Emerald Mutual Fund Advisers Trust132,413$1.08M
Profund Advisors LLC98,317$803.3K
Lion Point Capital, LP42,500$347.2K
Harbor Capital Advisors, Inc.41,715$341.0K
Denali Advisors LLC36,300$296.6K
E Fund Management Co., Ltd.30,342$247.9K
American International Group, Inc.24,367$199.1K
SG Americas Securities, LLC17,968$147.0K
Bank of Montreal16,832$141.1K
Marshall Wace, LLP16,581$135.5K
Principal Financial Group Inc13,129$107.3K
Handelsbanken Fonder AB12,000$98.0K
Aquatic Capital Management LLC7,300$59.6K
Quantbot Technologies LP4,900$40.0K
Pacer Advisors, Inc.2,984$24.4K
Metropolitan Life Insurance Co2,616$21.4K
Versant Capital Management, Inc94$768
Private Trust Co NA83$678
Truvestments Capital LLC80$654
Riggs Asset Managment Co. Inc.58$474
Global Retirement Partners, LLC32$261
Nelson, Van Denburg & Campbell Wealth Management Group, LLC8$65

Not filed for Q2 2024 yet (2)

Institutions that held Replimune Group, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding REPL in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG37,859$309.3K
Cutler Group LP700$5.00K